Streetbeat News

Products Services

LUMN

Recent options trading trends indicate a bullish stance on Lumen Technologies (NYSE:LUMN) by wealthy investors. Benzinga's options scanner detected 14 unusual trades, with a split sentiment of 57% bullish and 35% bearish. The trades suggest a targeted price range of $0.5 to $10.0 for LUMN over the last 3 months. Lumen Technologies, a major telecommunications carrier, has shifted focus towards enterprise services. The stock is currently priced at $7.25, down 0.41%, with RSI indicators suggesting it may be overbought.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:16 pm

RNA

Goldman Sachs has initiated coverage on Avidity Biosciences (NASDAQ:RNA) with a Buy rating and a $59 price target, citing the company's promising RNA therapeutics platform for rare diseases. Avidity's lead asset, del-desiran, is in Phase 3 trials for myotonic dystrophy, with potential blockbuster sales. The company also has promising candidates for other muscular dystrophies.

Portfolio Pulse from Vandana Singh

September 24, 2024 | 6:15 pm

NTES

NetEase shares rose by 7.22% due to a monetary stimulus package from the People's Bank of China, which cut reserve requirement ratios and policy rates. This move is expected to benefit sectors like online gaming and e-commerce, where NetEase is a key player.

Portfolio Pulse from Henry Khederian

September 24, 2024 | 6:15 pm

BTCUSD

MNWUSD

The article discusses the rising food inflation in the U.S., with former President Trump blaming Democrats, while experts suggest blockchain as a potential solution. The Federal Reserve has lowered interest rates to prevent an economic slowdown. Trump has positioned himself as a Bitcoin-friendly candidate, recently making his first Bitcoin transaction.

Portfolio Pulse from Justin Roberti

September 24, 2024 | 6:11 pm

SEEL

Seelos Therapeutics (NASDAQ:SEEL) shares surged over 72% after signing a material transfer agreement with the U.S. Army to supply intranasal racemic ketamine (SLS-002) for a PTSD clinical trial. The trial, funded by the Department of Defense, will assess the drug's effectiveness and safety for military personnel and veterans.

Portfolio Pulse from Dylan Berman

September 24, 2024 | 6:06 pm

MSFT

Microsoft has announced a $1.3 billion investment over the next three years to enhance cloud and AI capabilities in Mexico. This move aims to empower the region with advanced technology solutions.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:03 pm

GOLD

Financial giants have shown a bullish interest in Barrick Gold (NYSE:GOLD) through options trading, with 54% of trades being bullish. The stock is currently trading at $20.45, with a price target of $24.0 set by analysts. The options activity suggests a price range of $13.0 to $27.0.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 5:45 pm

DJT

SPY

Donald Trump, the Republican Presidential Nominee, announced plans to establish special zones on federal land with ultra-low taxes and regulations to benefit American producers. This policy could impact various sectors by potentially boosting domestic production.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 5:43 pm

PARA

Paramount's '60 Minutes' may feature back-to-back interviews with Donald Trump and Kamala Harris, potentially boosting viewership and advertising revenue ahead of the 2024 election. This could positively impact Paramount's stock, which has been down 27% year-to-date.

Portfolio Pulse from Chris Katje

September 24, 2024 | 5:42 pm

USO

Donald Trump, the Republican Presidential Nominee, announced plans to reinstate oil and gas leases in Alaska's ANWR, which had been previously canceled. This could impact energy markets and related stocks.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 5:41 pm